DK152497B - METHOD FOR PREPARING 8-SUBSTITUTED 2-AMINO-5-OXO-5,8-DIHYDROPYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID - Google Patents

METHOD FOR PREPARING 8-SUBSTITUTED 2-AMINO-5-OXO-5,8-DIHYDROPYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID Download PDF

Info

Publication number
DK152497B
DK152497B DK100275AA DK100275A DK152497B DK 152497 B DK152497 B DK 152497B DK 100275A A DK100275A A DK 100275AA DK 100275 A DK100275 A DK 100275A DK 152497 B DK152497 B DK 152497B
Authority
DK
Denmark
Prior art keywords
oxo
pyrimidine
dihydropyrido
reaction
group
Prior art date
Application number
DK100275AA
Other languages
Danish (da)
Other versions
DK100275A (en
DK152497C (en
Inventor
Marcel Pesson
Original Assignee
Bellon Labor Sa Roger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellon Labor Sa Roger filed Critical Bellon Labor Sa Roger
Publication of DK100275A publication Critical patent/DK100275A/da
Publication of DK152497B publication Critical patent/DK152497B/en
Application granted granted Critical
Publication of DK152497C publication Critical patent/DK152497C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

iin

DK 152497 BDK 152497 B

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af 8-substituerede 2-amino-5-oxcr5,8-dihydropy-rido[2,3-d]pyrimidin-6-carboxylsyrer med den almene formelThe present invention relates to a particular process for the preparation of 8-substituted 2-amino-5-oxocr5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acids of the general formula

^rV00H^ rV00H

Æ. I II I (Ilia) '"R' lo R" 5 som er bemærkelsesværdige antibakterielle midler.Æ. I II I (Ilia) '"R" lo R "5 which are remarkable antibacterial agents.

2 I denne formel er R en alkylgruppe med 1-5 carbonatomer, fortrinsvis 1-2 carbonatomer, en fenylgruppe eller benzyl-gruppe, R og R', der kan være ens eller forskellige, hver er hydrogenatomer eller alkylgrupper med 1-5 carbonatomer 10 eller sammen med nitrogenatomet, hvortil de er bundet, danner en piperazinylgruppe, methyl—4-piperazinylgruppe, for-myl-4-piperazinylgruppe, (4-(3-hydroxyethyl)-piperazinylgruppe eller pyrrolidinogruppe.In this formula, R is an alkyl group having 1-5 carbon atoms, preferably 1-2 carbon atoms, a phenyl group or benzyl group, R and R 'which may be the same or different, each being hydrogen atoms or alkyl groups having 1-5 carbon atoms. or together with the nitrogen atom to which they are attached form a piperazinyl group, methyl-4-piperazinyl group, formyl-4-piperazinyl group, (4- (3-hydroxyethyl) -piperazinyl group or pyrrolidino group).

fremgangsmåden er ejendommelig ved, at man ansætter en 8-substitueret 15 2-alkylsulfonyl-6~carbalkoxy-5roxo-5,8-dihydropyrido[2,3-d]-pyrimidin med formlen Ithe process is characterized by employing an 8-substituted 2-alkylsulfonyl-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine of formula I

0 - Jl /COOE3 * - ΐ-χχΥ 12 3 hvor R , R og R , der kan være ens eller forskellige, er alkygrupper med 1-5 carbonatomer, fortrinsvis 1-2 carbona-2 20 tomer, og R desuden kan være en fenylgruppe eller benzyl-gruppe,med en amin af formlen 'v 20 - J1 / COOE3 * - ΐ-χχΥ 12 3 wherein R, R and R, which may be the same or different, are alkyl groups having 1-5 carbon atoms, preferably 1-2 carbon atoms, and R may also be a phenyl group or benzyl group, with an amine of formula 'v 2

DK 152497 BDK 152497 B

hvor R og R' har den ovennævnte betydning, hvorefter en dannet 8-substitueret 2-amino-6-carbalkoxy-5-oxo-5,8-dihydropy-rido[2,3-d]pyrimidin med formlen IIIwherein R and R 'have the above meaning, after which an 8-substituted 2-amino-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine of formula III is formed

il 3il 3

[I OOOR[IN OOOR

/'E\ iTAlj (iii) 'R' 2/ 'E \ iTAlj (iii)' R '2

RR

2 3 5 hvor R, R', R og R har den ovennævnte betydning, hydroly seres.Wherein R, R ', R and R are as defined above, hydrolyzed.

Udgangsprodukterne, de 8-substituerede 2-alkylsulfonyl-6-carbalkoxy-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidiner med formlen I udmærker sig ved deres store reaktionsdygtighed, 10 som skyldes attraktionsvirkningen af alkylsulfonylgruppen.The starting products, the 8-substituted 2-alkylsulfonyl-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidines of formula I, are distinguished by their high reactivity, 10 due to the attraction effect of the alkylsulfonyl group.

Af denne grund kan de indgå i talrige nucleofile reaktioner. Især reagerer de med ammoniak og primære og sekundære fede aminer eller heterocykliske aminer og giver i meget gode udbytter 8-substituerede 2-amino-6-carbalkoxy-5,8-dihydropy-15 rido[2,3-d]pyrimidiner og deres 2-monoalkylamino- eller 2- dialkylaminoderivater (III) ifølge reaktionsskemaet: (OC«A—> ('For this reason, they can be involved in numerous nucleophilic reactions. In particular, they react with ammonia and primary and secondary fatty amines or heterocyclic amines and in very good yields yield 8-substituted 2-amino-6-carbalkoxy-5,8-dihydropyrido [2,3-d] pyrimidines and their 2 -monoalkylamino or 2-dialkylamino derivatives (III) according to the reaction scheme: (OC

'~R' * -R* I'~ R' * -R * I

R2 i2 (I) R (III) 12 3 I disse formler har R , R , R , R og R* de ovenfor anførte betydninger.R2 In2 (I) R (III) 12 3 In these formulas, R, R, R, R and R * have the meanings given above.

20 Hydrolyse af estere (III) giver tilsvarende syrer (Illa), hvoraf nogle er værdifulde antibakterielle midler til behandling af sygdomme, der skyldes gramnegative bakterier, og som allerede er beskrevet i fransk patent nr. 2.194.420.20 Hydrolysis of esters (III) yields similar acids (IIa), some of which are valuable antibacterial agents for the treatment of Gram-negative bacteria diseases already described in French Patent No. 2,194,420.

DK 152497 BDK 152497 B

33

Trods den store reaktionsdygtighed af alkylsulfcnylderivatet udføres fremgangmåden fortrinsvis på den måde, at reaktionen mellem alkylsulfonylderivatet (I) oq aminen udføres ved en temperatur mellem 60 og 120° C, idet der herved opnås en bedre reak-5 tionshastighed.In spite of the high reactivity of the alkyl sulfonyl derivative, the process is preferably carried out in that the reaction between the alkyl sulfonyl derivative (I) and the amine is carried out at a temperature between 60 and 120 ° C, thereby obtaining a better reaction rate.

Det er bemærkelsesværdigt, at reaktionsdygtigheden af methyl-sulfonylgruppen er således, at man uden vanskelighed kan arbejde i polære opløsningmidler. Ifølge opfindelsen udføres reaktionen derfor fortrinsvis i et opløsningsmiddel, der muliggør 10 fuldstændiq opløsning, af. reaktionsdel tagerne, især en alkylalkchol med 1-5 carbonatomer.It is noteworthy that the reactivity of the methylsulfonyl group is such that one can easily work in polar solvents. Therefore, according to the invention, the reaction is preferably carried out in a solvent which allows 10 complete dissolution of. the reaction moieties, especially an alkyl alcohol having 1-5 carbon atoms.

Reaktionen udføres under anvendelse af aminen i overskud i forhold til sulfonen, f.eks. 2 mol amin pr. mol sulfon. Man kan ligeledes anvende ækvimolekulære mængder af de to reaktionsdeltagere i nærværelse af mindst et mol af et': basisk mid-15 del, f.eks. en tertiær amin, såsom triethylamin, pr. mol sulfon.The reaction is carried out using the amine in excess of the sulfone, e.g. 2 moles of amine per ml. mole of sulfone. Equimolecular amounts of the two reaction participants may also be used in the presence of at least one mole of a basic agent, e.g. a tertiary amine such as triethylamine per mole of sulfone.

Den anvendte mængde opløsningmiddel er således, at reaktions-deltagerne findes deri i en koncentration mellem 10 og 25%.The amount of solvent used is such that the reaction participants are present therein at a concentration between 10 and 25%.

I almindelighed er reaktionen fuldendt efter en varighed af opvarmningen mellem 1 og 5 timer. De aminerede derivater 20 (III) isoleres i overensstemmelse med deres opløseligheds- egenskaber ved at anvende almindelige fremgangsmåder, som er beskrevet i de følgende eksempler.In general, the reaction is completed after a duration of heating between 1 and 5 hours. The aminated derivatives 20 (III) are isolated according to their solubility properties using ordinary methods described in the following examples.

I de tilfælde, hvor man bringer ammoniak eller aminer med kogepunkt lavere end den temperatur, som er nødvendig til reak-25 tionen, til at reagere, kan man arbejde i autoklav med et overskud af amin. Det er imidlertid muligt og særligt interessant at udføre denne operation ved sædvanligt tryk ved at lade en strøm af luftformig ammoniak eller amin boble gennem opløsningen af sulfonen i det valgte opløsningsmiddel, 30 som holdes under tilbagesvaling.In the case of reacting ammonia or amines with boiling point lower than the temperature required for the reaction to react, one can work in autoclave with an excess of amine. However, it is possible and particularly interesting to carry out this operation at usual pressure by bubbling a stream of gaseous ammonia or amine through the solution of the sulfone in the selected solvent which is kept under reflux.

En særlig interessant anvendelse af fremgangsmåden ligger i direkte fremstilling af 6-carbethoxy-8-ethyl-5-oxo-2-pipe-A particularly interesting application of the process lies in the direct preparation of 6-carbethoxy-8-ethyl-5-oxo-2-pipe.

DK 152497 BDK 152497 B

4 reaktion af 6-carbethoxy-8-ethyl-2-TæthyIsulfonyl-5--oxo-5,8-dihydropyrido[2,3-d]pyrimidin (V) med piperazin anvendt i fom af he'xahvdrat:4 reaction of 6-carbethoxy-8-ethyl-2-tertylisulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine (V) with piperazine used in the form of hexahydrate:

° P° P

O™+ —» »3 XXXO ™ + - »» 3 XXX

i Ii

C,H, C2H5 (V) 25 (IV) 5 Esteren (IV) hydrolyseres derefter til den tilsvarende syre, som hår udmærkede antibakterielle egenskaber.C, H, C2H5 (V) 25 (IV) The ester (IV) is then hydrolyzed to the corresponding acid, which has excellent antibacterial properties.

Det er velkendt, at esteren (IV) ikke kan fås direkte ved indvirkning af 6-carbethoxy-2-chlor-8-ethyl-5-oxo-5,8-di-10 hydropyrido[2,3-d]pyrimidin på piperazin under normale be-tinqelser. Den store reaktionsdvgtighed af haloqenatomet muliggør derfor faktisk ikke en tilstrækkelig selektiv reaktion, og hovedproduktet fra reaktionen er det Ν,Ν'-disub- · stituerede derivat af piperazin (IVbis). Fremstillingen 15 af esteren (IV) nødvendiggør derfor, at man går over det N-formylerede derivat af piperazin, som beskrevet i ansøgning nr. 4229/73.It is well known that the ester (IV) cannot be obtained directly by the action of 6-carbethoxy-2-chloro-8-ethyl-5-oxo-5,8-di-hydropyrido [2,3-d] pyrimidine on piperazine. under normal conditions. Therefore, the high reactivity of the halogen atom does not, in fact, allow for a sufficiently selective reaction, and the main product of the reaction is the Ν, Ν'-disubstituted derivative of piperazine (IVbis). Therefore, preparation 15 of the ester (IV) necessitates passing the N-formylated derivative of piperazine, as described in Application No. 4229/73.

Hs^OCO. ' jj . COOC2H5 /γγHs ^ OCO. 'yeah. COOC2H5 / γγ

ί N A, NXj Jί N A, NXj J

C„H[- (IVbis) C2H5C „H [- (IVbis) C₂H5

Z DZ D

Derimod er det muligt at få esteren (IV) med udmærkede ud-20 bytter direkte ved indvirkning af methylsulfonen (V) på pi-perazinhexahydrat,.In contrast, it is possible to obtain the ester (IV) with excellent yields directly by the action of the methyl sulfone (V) on piperazine hexahydrate.

Man arbejder fortrinsvis med et overskud (1,5-2 mol) piperazin i forhold til sulfonen (1 mol) og i nærværelse af et overskud (2-5 mol) af en alifatisk tertiær base, såsom triethyl-25 5Preferably, an excess (1.5-2 moles) of piperazine is employed relative to the sulfone (1 mole) and in the presence of an excess (2-5 moles) of an aliphatic tertiary base such as triethyl-5

DK 152497BDK 152497B

amin. Piperazinen og den tertiære base i opløsning (koncentration af reaktionsdeltagerne 10-20%) i en alkylalkohol, f.eks. . ethanol, omrøres og opvarmes under tilbagesvaling. Man tilsætter dråbevis i løbet af ca. 1 time en opløsning af sulfo-5 nen (V) (.1 mo]) i 3-5 rumfang af et egnet opløsningsmiddel, f.eks. dimethylformamid (DMF). Efter endt tilsætning afsluttes reaktionen ved at fortsætte opvarmningen under tilbagesvaling i 30 minutter til 1 time. Opløsningsmidlerne afdampes i vacuum. Remanensen opløses i en fortyndet opløsning af 10 en mineralsyre eller stærk organisk syre (f.eks. methansulfon-syre). En ringe mængde uopløst stof fraskilles ved filtrering. Opløsningen gøres alkalisk ved tilsætning af et alkalimetal-carbonat, og reaktionsproduktet ekstraheres med et egnet opløsningsmiddel, f.eks. chloroform. Afdampning af opløsnings-15 midlet efterlader som remanens esteren (IV). Renset ved omkrystallisation i benzen fås det med et udbytte på ca. 80%.amine. The piperazine and the tertiary base in solution (concentration of the reaction participants 10-20%) in an alkyl alcohol, e.g. . ethanol, stirred and heated at reflux. Drops are added over approx. 1 hour a solution of the sulfone (V) (.1 mo]) in 3-5 volumes of a suitable solvent, e.g. dimethylformamide (DMF). After addition is complete, the reaction is terminated by continuing to reflux for 30 minutes to 1 hour. The solvents are evaporated in vacuo. The residue is dissolved in a dilute solution of a mineral acid or strong organic acid (e.g., methanesulfonic acid). A small amount of undissolved substance is separated by filtration. The solution is made alkaline by the addition of an alkali metal carbonate and the reaction product is extracted with a suitable solvent, e.g. chloroform. Evaporation of the solvent leaves as the residue ester (IV). Purified by recrystallization in benzene it is obtained with a yield of approx. 80%.

Det er kendt, at amineringsreaktioner i 2-stilling i kernen i derivaterne af pyrido[2,3-d]pyrimidin kan udføres ved indvirkning af aminerne på 2-methylmerkaptoderivaterne eller på 20 2-chlorderivaterne.It is known that 2-position amination reactions in the nucleus of the pyrido [2,3-d] pyrimidine derivatives can be performed by the action of the amines on the 2-methylmercapto derivatives or on the 2-chloro derivatives.

Anvendelsen af alkylsulfonylerede derivater ifølge opfindelsen er et betydeligt teknisk fremskridt. De alkylsulfonylerede qrupper har faktisk en reaktionsdygtighed, der ligger mellem reaktionsdyg.tigheden af alkylmerkaptogrupperne (de 25 mindst reaktionsdvgtige) og halogenderivaterne (de mest reaktiondygtige) .The use of alkylsulfonylated derivatives of the invention is a considerable technical advance. In fact, the alkylsulfonylated groups have a reactivity which lies between the reactivity of the alkyl mercapto groups (the least reactive) and the halogen derivatives (the most reactive).

Sammenlignet med 2-alkylmerkaptoderivaterne muliggør alkyl-sulfonylderivaterne at udføre amineringsreaktionerne ved lavere temperaturer og at undgå at arbejde under tryk. Des-30 uden bevirker reaktioner udført med førstnævnte udvikling af giftige merkaptaner og ubehagelig lugt. Reaktionerne af sidstnævnte er lugtløse, hvilket er en anden fordel ud fra et forureningssynspunkt. 1 forhold til 2-halogenerede derivater muliggør den mindre 6Compared to the 2-alkyl mercapto derivatives, the alkyl-sulfonyl derivatives enable the amination reactions to be carried out at lower temperatures and to avoid working under pressure. Des-30 without causing reactions with the former development of toxic mercaptans and unpleasant odors. The reactions of the latter are odorless, which is another advantage from a pollution point of view. 1 relative to 2-halogenated derivatives allows the smaller 6

DK 152497BDK 152497B

mobilitet af sulfonylgruppen at arbejde med flere forskellige opløsningsmidler og især, som eksemplet med piperazin viser, at opnå en større selektivitet, hvor det drejer sig om komplekse reaktioner.mobility of the sulfonyl group to work with several different solvents and, in particular, as the example of piperazine shows, to achieve a greater selectivity in the case of complex reactions.

5 Udgangsprodukterne er hidtil ukendte forbindelser med føl gende almene formel (I) 0 3The starting products are novel compounds of the following general formula (I) 0 3

11 COOR11 COOR

0 r1- s—X j (i) 0 l2 12 3 hvor R , R , og R , der kan være ens eller forskellige, er alkylgrupper med 1-5 carbonatomer, fortrinsvis 1-2 carbon-2 10 atomer, og R i øvrigt kan være en fenylgruppe eller benzyl-gruppe.Wherein R, R, and R, which may be the same or different, are alkyl groups having 1-5 carbon atoms, preferably 1-2 carbon atoms, and R 1 otherwise may be a phenyl group or benzyl group.

Disse produkter kan fås af en 8-substitueret 2-alkylmerkapto-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d]pyrimidin med formlen (II) 9 · ,These products can be obtained from an 8-substituted 2-alkyl mercapto-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine of formula (II) 9 ·,

11 COOR11 COOR

»V/ 15 H1 - s —(II) 12 især en 2-alkylmerkapto-β-earbéthoxy-8-ethyl-5-oxo-5,8 dihydropy-rido[2,3-d]pyrimidin (Ila), ved oxidation med et mildt oxi-· dationsmiddel, der almindeligvis anvendes til dette formål, såsom kaliumpermanganat, kaliumbi.chromateller oxygen. Det 20 er dog mest hensigtsmæssigt at anvende et halogen, især chlor, i vandigt medium. I sidstnævnte tilfælde kan reaktionen skematiseres som følger: 0 .° 7»V / 15 H1 - s - (II) 12 in particular a 2-alkyl mercapto-β-earbethoxy-8-ethyl-5-oxo-5,8 dihydropyrido [2,3-d] pyrimidine (IIa), upon oxidation with a mild oxidizing agent commonly used for this purpose such as potassium permanganate, potassium bi-chromate or oxygen. However, it is most convenient to use a halogen, especially chlorine, in aqueous medium. In the latter case, the reaction can be schematized as follows: 0 ° 7

DK 152497BDK 152497B

^ £OOCX^ £ OOCX

N ιΓιι f II i R1-S—L Ji jJ + 2C1_+2H00-^R1-S0„-k* X J „ 2 2 2 N + 2 HC1 I | ' (Ila) C2H5N ιΓιι f II i R1-S — L Ji jJ + 2C1_ + 2H00- ^ R1-S0 „-k * X J„ 2 2 2 N + 2 HC1 I | (IIa) C 2 H 5

Reaktionen udføres ved at lade en strøm af luftformigt chlor ved en temperatur mellem 0 og 25° C passere ind i en kraftigt omrørt vandig suspension af 2-alkylmerkaptoderivatet (II), 5 indtil vægtforøgelsen af reaktionsblandingen svarer til 90-105% af den teoretiske halogenmasse, som kan beregnes af foregående ligning, eller 2 mol halogen til 1 mol alkylmerkap-toderivat (II).The reaction is carried out by passing a stream of gaseous chlorine at a temperature between 0 and 25 ° C into a vigorously stirred aqueous suspension of the 2-alkyl mercapto derivative (II), 5 until the weight increase of the reaction mixture corresponds to 90-105% of the theoretical halogen mass. , which can be calculated from the previous equation, or 2 moles of halogen to 1 mole of alkylmercapode derivative (II).

Når denne vægtforøgelse er opnået, standses tilførslen af halogen, og man lader reaktionen fortsætte under omrøring ved 10 en temperatur mellem 0 og 25° C indtil fuldstændig omdannelse af udgangsmaterialet, hvilket afhængende af betingelserne kræver 10 minutter til. 1 time.When this weight gain is achieved, the halogen supply is stopped and the reaction is allowed to proceed with stirring at a temperature between 0 and 25 ° C until complete conversion of the starting material, which, depending on the conditions, requires 10 minutes. 1 hour.

Efter eventuel fortynding ved tilsætning af vand bliver det faste reaktionsprodukt lufttørret, vasket og omkrystallise-15 ret i et egnet opløsningmiddel.After any dilution by adding water, the solid reaction product is air dried, washed and recrystallized in a suitable solvent.

Under denne oxidation er det nødvendigt at undgå anvendelse af et stort overskud af halogen, som begunstiger dannelsen af biprodukter, og som giver risiko for at bevirke en fomindskelse af det generelle udbytte mellem 80 og 90%.During this oxidation, it is necessary to avoid the use of a large excess of halogen, which favors the formation of by-products, and which gives the risk of reducing the overall yield between 80 and 90%.

20 Reaktionens forløb afhænger af karakteren af mediet: I vand er reaktionen langsom, sandsynligvis på grund af den meget ringe opløselighed af alkylmerkaptoderivaterne (II). Derfor er det mest hensigtsmæssigt at anvende vandige opløsninger fortyndet med vandopløselige organiske opløsningsmidler, så-25 som lavere alkoholer og især methanol, eller eddikesyre.The course of the reaction depends on the nature of the medium: In water, the reaction is slow, probably due to the very poor solubility of the alkyl mercapto derivatives (II). Therefore, it is most convenient to use aqueous solutions diluted with water-soluble organic solvents, such as lower alcohols and especially methanol, or acetic acid.

DK 152497 BDK 152497 B

88

Disse opløseliggørende tilsætninger kan anvendes i koncentrationer mellem 5 og 50%.These solubilizing additives can be used at concentrations between 5 and 50%.

Med koncentrationer af tilsætninger over 20% kan man under oxiiationsreaktionen iagttage en forbigående eller definitiv 5 opløsning af det anvendte alkylmerkaptoderivat. Med svagere koncentrationer (5-10%) giver reaktionens forløb sig udtryk i en modifikation af egenskaberne af det faste stof i suspension, som kan bedømmes på prøver af sidstnævnte ved bestemmelse af en passende fysisk konstant, f.eks. smeltepunktet.With concentrations of additives above 20%, a transient or definitive solution of the alkyl mercapto derivative used can be observed during the oxidation reaction. At weaker concentrations (5-10%), the course of the reaction is expressed in a modification of the properties of the solid in suspension, which can be evaluated on samples of the latter by determining an appropriate physical constant, e.g. the melting point.

10 I stedet for chlorgas kan man anvende enhver anden fremgangsmåde, der gør det muligt at frigøre halogen i nativ tilstand i reaktionsmediet, f.eks. alkalimetalhypchloriter eller oxy-generet vand, der virker på én suspension af forbindelserne (II) i saltsyre i nærværelse af opløseliggørende tilsætninger.Instead of chlorine gas, any other method which allows the release of halogen in the native state in the reaction medium, e.g. alkali metal hypchlorites or oxygenerated water acting on one suspension of the compounds (II) in hydrochloric acid in the presence of soluble additives.

15 De følgende eksempler anføres for at illustrere fremgangsmå-’ den ifølge opfindelsen, idet eksempel 1 illustrerer fremstillingen af det anvendte udgangsmateriale.The following examples are given to illustrate the process of the invention, with Example 1 illustrating the preparation of the starting material used.

Produkterne i eksemplerne 2-5 og eksempel 7 har allerede været beskrevet i ovennævnte franske patent, ligesom de syrer 20 der fås ved deres hydrolyse.The products of Examples 2-5 and Example 7 have already been described in the aforementioned French patent, as are the acids 20 obtained by their hydrolysis.

Eksempel 1 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [ 2,3-d 3 pyrimidin.Example 1 6-Carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine.

(formel I, R1 = CH3, R2 = C^) .(formula I, R1 = CH3, R2 = C3).

3 25 I en 500 cm glaskolbe udstyret med mekanisk omrører og termometer og anbragt i et isbad omrøres kraftigt 29,3 g (0,1 mol) 6-carbethoxy-8-ethyl-2-methylmerkapto-5-oxo-5,8-dihy- 3 dropyrido[2,3-d]pyrimidin i en opløsning af 15 cm eddikesy- 3 * re i 285 cm vand, og man tilleder en strøm af chlor med en 30 sådan hastighed, at temperaturen forbliver mellem 10 og 15° C. Kolben med indhold, der er vejet før indføringen af luftarten. venes iaen med reaelmæssiae mellemrum.In a 500 cm glass flask equipped with mechanical stirrer and thermometer and placed in an ice bath, vigorously stir 29.3 g (0.1 mole) of 6-carbethoxy-8-ethyl-2-methylmercapto-5-oxo-5.8 dihydro-3-dropyrido [2,3-d] pyrimidine in a solution of 15 cm acetic acid in 285 cm water, and a stream of chlorine is allowed at a rate such that the temperature remains between 10 and 15 ° C. .The flask with contents weighed before the introduction of the gas. veins at a regular intervals.

99

DK 152497 BDK 152497 B

Når vægtforøgelsen er 13 g (teoretisk for 2 mol chlor: 14,2 g), varighed ca. 1 time, standses gasstrømmen, og blandingen omrøres endnu i 30 minutter ved 10° C.When the weight gain is 13 g (theoretical for 2 moles of chlorine: 14.2 g), duration approx. 1 hour, the gas stream is stopped and the mixture is stirred for another 30 minutes at 10 ° C.

33

Efter tilsætning af 100 cm vand. lufttørres bundfaldet, vaskes med 3 5 vand, derpå med ethanol (2 x 35 cm ) og tørres i vacuum. Man får 26,6 g (udbytte 81,8%) 6—carbethoxy-8-ethyl-2-methylsul-fony1-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin, smeltepunkt 176° C. En prøve omkrystalliseret af isopropanol bevarer samme smeltepunkt.After adding 100 cm of water. The precipitate is air dried, washed with water, then with ethanol (2 x 35 cm) and dried in vacuo. 26.6 g (yield 81.8%) of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine are obtained, m.p. 176 ° C. A sample recrystallized from isopropanol maintains the same melting point.

10 Analyse for C^H-j^NgO^S (325,27)Analysis for C ^ HH-jNgO₂S (325.27)

Beregnet % C 48,00 H 4,65 N 12,92 S 9,82 Fundet % C 47,83 H 4,74 N 13,20 S 9,65 I de følgende eksempler 2-7 anvendes produktet fra dette eksempel 1 som mellemprodukt til fremstilling af de 8-substi-15 tuerede 2-amino-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-6- carboxy1syrer, hvis antibakterielle virkning er kendt.Calculated% C 48.00 H 4.65 N 12.92 S 9.82 Found% C 47.83 H 4.74 N 13.20 S 9.65 In the following Examples 2-7, the product of this Example 1 is used as intermediate for the preparation of the 8-substituted 2-amino-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acids, the antibacterial action of which is known.

Eksempel 2Example 2

En opløsning af piperazinhe'xahydrat (3,9 g, 0,02 mol) og 3 triethylamin (2,02 g, Q,Q2 mol) i 50 cm ethanol opvarmes 20 under tilbagesvaling. M:an tilsætter dråbevis i løbet af 1 time 3,25 g (0,02. mol) 6-carbethoxy-8-ethyl-2-methylsulfonyl- 5- OXO-5,8-dihydropyrido[2,3-d]pyrimidin fra eksempel 1 i op- 3 løsning i 15 cm DMF.A solution of piperazine hexahydrate (3.9 g, 0.02 mol) and 3 triethylamine (2.02 g, Q, Q2 mol) in 50 cm of ethanol is heated to reflux. M: an added 3.25 g (0.02 mole) of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5- OXO-5,8-dihydropyrido [2,3-d] pyrimidine dropwise over 1 hour. from Example 1 in solution in 15 cm DMF.

Opløsningsmidlerne afdampes i vacuum, og remanensen optages 25 i 20 cm 1,5 N HC1. En smule uopløseligt stof fjernes ved ekstraktion med chloroform.Den vandige opløsning gøres alkalisk ved tilsætning af Na^O^, og reaktionsproduktet ekstra-heres med chloroform (5 x 10 cm ). De organiske ekstrakter forenes, og opløsningen affarves ved omrøring med dyriske 30 kul og filtreres. Inddampning giver 2,65 g (udbytte 80%) 6- carbethoxy-8-ethyl-2-piperazinyl-5-oxo-5,8-dihydropyridoThe solvents are evaporated in vacuo and the residue is taken up in 20 cm 1.5 N HCl. Slightly insoluble matter is removed by chloroform extraction. The aqueous solution is made alkaline by the addition of Na 2 O 4 and the reaction product is extracted with chloroform (5 x 10 cm). The organic extracts are combined and the solution is decolorized by stirring with animal charcoal and filtered. Evaporation gives 2.65 g (yield 80%) of 6-carbethoxy-8-ethyl-2-piperazinyl-5-oxo-5,8-dihydropyrido

DK 152497BDK 152497B

ίοίο

OISLAND

[2,3-d]pyrimidin, smeltepunkt 156 C.[2,3-d] pyrimidine, mp 156 ° C

Analyse for ci6H2iN5°3 (331,37)Analysis for ci6H2iN5 ° 3 (331.37)

Beregnet % C 57,99 H 6,39 N 21,14 Fundet % C 57,98 H 6,23 N 21,39 5 Hydrolysen af denne ester giver den tilsvarende syre. Til 3 2,65 g af esteren i suspension i 30 cm 75% ethanol sættes 3 22 cm INnatriumcarbonat, og blandingen omrøres i 2 timer og 30 minutter ved omgivelsernes temperatur. Opløsningen syrnes 3 med 1,26 cm koncentreret eddikesyre. Efter henstand i køle-10 skab lufttørres bundfaldet, vaskes med alkohol og tørres derpå i vacuum. Man får 2,29 g 8-ethyl-2-piperazinyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-6-carboxylsyre, smeltepunkt 260-262° C (Koflerblok) under dekomponering.Calculated% C 57.99 H 6.39 N 21.14 Found% C 57.98 H 6.23 N 21.39 5 The hydrolysis of this ester gives the corresponding acid. To 3.65 g of the ester in suspension in 30 cm 75% ethanol is added 3 22 cm 1 IN sodium carbonate and the mixture is stirred for 2 hours and 30 minutes at ambient temperature. The solution is acidified 3 with 1.26 cm of concentrated acetic acid. After standing in a refrigerator, the precipitate is air dried, washed with alcohol and then dried in vacuo. There is obtained 2.29 g of 8-ethyl-2-piperazinyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acid, m.p. 260-262 ° C (Kofler block) under decomposition.

Analyse for ci4Hi7N5°3 (303,32) 15 Beregnet % C 55,43 H 5,65 N 23,09 Fundet % C 55,68 H5,67 N 23,25Analysis for C 14 H 7 N 5 ° 3 (303.32) Calculated% C 55.43 H 5.65 N 23.09 Found% C 55.68 H5.67 N 23.25

Eksempel 3 1,6 g 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihy-dropyrido[2,3-d]pyrimidin fra eksempel 1 og 1 g 1-methylpi- 3 20 perazin i 20 cm isopropanol opvarmes 1 time under tilbagesvaling. Opløsningsmidlet afdampes i vacuum, remanensen op- 3 tages i 40 cm af en mættet opløsning af Na„CO», og blanding- 3 o gen ekstraheres med 4 x 10 ciri chloroform. De forenede organiske faser inddampes. Remanensen omkrystalliseret af en 25 blanding af isopropyloxid (1 rumfang) og benzen (1 rumfang) giver 1,36 g (udbytte 79%) 6-carbethoxy-8-ethyl-5-oxo-2-(41-methylpiperazinyl)-5,8-dihydropyrido[2,3-d]pyrimidin, som smelter i to tempi. Smeltepunkt 146° C, derpå størkning og siden smeltepunkt 158° C.Example 3 1.6 g of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine from Example 1 and 1 g of 1-methylpiperazine in 20 cm of isopropanol is heated at reflux for 1 hour. The solvent is evaporated in vacuo, the residue is taken up in 40 cm of a saturated solution of Na 2 CO, and the mixture is extracted with 4 x 10 6 ciri chloroform. The combined organic phases are evaporated. The residue was recrystallized from a mixture of isopropyloxide (1 volume) and benzene (1 volume) to give 1.36 g (yield 79%) of 6-carbethoxy-8-ethyl-5-oxo-2- (41-methylpiperazinyl) -5 8-dihydropyrido [2,3-d] pyrimidine, which melts in two temps. Melting point 146 ° C, then solidification and then melting point 158 ° C.

11 DK 152497 B11 DK 152497 B

Analyse for ci7H23N5°3 (345,39)Analysis for c17 H23 N5 ° 3 (345.39)

Beregnet S C 59,11 H 6,71 N 20,20Calculated S C 59.11 H 6.71 N 20.20

Fundet % C 59,23 H 6,68 N 20,42Found% C 59.23 H 6.68 N 20.42

Hydrolyse af denne ester ved tilsætning af en opløsning af 5 o N NaOH, omrøring ved 50-60 C i 2 timer ved omgivelsernes temperatur og syrning til pH 6 med eddikesyre giver 2-(4’-methyl-piperazinyl) -8-ethyl-5-oxo-5,8-dihydropyridc[2,3-d]pyrimidin-6-carboxylsyre, smeltepunkt 227° C.Hydrolysis of this ester by adding a solution of 5N NaOH, stirring at 50-60 ° C for 2 hours at ambient temperature and acidifying to pH 6 with acetic acid gives 2- (4'-methyl-piperazinyl) -8-ethyl 5-oxo-5,8-dihydropyridc [2,3-d] pyrimidine-6-carboxylic acid, m.p. 227 ° C.

i oin Island

Analyse for ci5H]_9N5°3 (317,34)Analysis for ci 5 H] 9 N 5 ° 3 (317.34)

Beregnet % C 56,77 H 6,04 N 22,07Calculated% C 56.77 H 6.04 N 22.07

Fundet % C 56,69 H 6,23 N 22,35 15Found% C 56.69 H 6.23 N 22.35

Eksempel 4 10,7 g 6- cårbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydro- pyrido[2,3-d]pyrimidin (0,03 mol), beskrevet i eksempel 1, 7,8 20 2 g β-hydroxyethylpiperazin (0,06 mol) og 100 cm isopropanol opvarmes under til.bagesvaling i 2 timer. Efter afkøling sæt- 3 tes der til blandingen 50 cm isopropyloxi'd. Bundfaldet luft- 3 tørres, vaskes med 50 cm af en blanding af 30 rumfang isopropanol og 70 rumfang isopropyloxid. Man får 10,2 g (udbytte 25 91%) 6-carbethoxy-8-ethyl-5-oxo-2-(4-p-hydroxyethyl)-pipera-zinyl-5,8-dihydropyrido[2,3-d]pyrimidin, smeltepunkt 172° C.Example 4 10.7 g of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine (0.03 mol) described in Examples 1, 7 , 8 20 2 g of β-hydroxyethylpiperazine (0.06 mol) and 100 cm of isopropanol are heated under reflux for 2 hours. After cooling, the mixture is added 50 cm of isopropyloxy. The precipitate is air dried, washed with 50 cm of a mixture of 30 volumes of isopropanol and 70 volumes of isopropyloxide. 10.2 g (yield 91%) of 6-carbethoxy-8-ethyl-5-oxo-2- (4-p-hydroxyethyl) -piperazinyl-5,8-dihydropyrido [2,3-d] are obtained. pyrimidine, m.p. 172 ° C.

Analyse for cigH25N5°4 (375,42) 30Analysis for cigH25N5 ° 4 (375.42) 30

Beregnet % C 57,58 H 6,71 N 18,60 Fundet % C 57,53 H 6,57 N 18,80Calculated% C 57.58 H 6.71 N 18.60 Found% C 57.53 H 6.57 N 18.80

Forsæbning af denne ester giver den tilsvarende syre. 10,2 g 3 af esteren og 40 cm ethanolisk natriumcarbonat omrøres i 2 3 5 timer ved omgivelsernes temperatur. Opløsningen neutralise-3 res med 2 cm koncentreret eddikesyre. Bundfaldet lufttørres, vaskes med vand og omkrystalliseres af ethanol. Man får 8,6 g 8-ethyl-5-oxo-2-(4-β-hydroxyethyl)-piperazinyl-5,8-dihydropy-The saponification of this ester gives the corresponding acid. 10.2 g of 3 of the ester and 40 cm of ethanolic sodium carbonate are stirred for 2 hours at ambient temperature. The solution is neutralized with 2 cm of concentrated acetic acid. The precipitate is air dried, washed with water and recrystallized from ethanol. 8.6 g of 8-ethyl-5-oxo-2- (4-β-hydroxyethyl) -piperazinyl-5,8-dihydropylamide are obtained.

12 DK 152497 B12 DK 152497 B

Analyse for ci6H2iN5°4 (347,37)Analysis for ci6H2iN5 ° 4 (347.37)

Beregnet % C 55,32 H 6,09 N 20,16Calculated% C 55.32 H 6.09 N 20.16

Pundet % C 54,96 H 6,04 N 19,92 5Pound% C 54.96 H 6.04 N 19.92 5

Eksempel 5 I en glaskolbe udstyret med tilbagesvaler og tilførselsrør for ammoniak, opvarmes under tilbagesvaling en suspension af 6.5 g (0,02 mol) 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo- 3 5,8-dihydropyrido[2,3-d]pyrimidin fra eksempel 1 i 40 cm ethanol under en hurtig strøm af NH^. Processen fortsættes, indtil smeltepunktet af det faste stof (oprindeligt 176° C) o „„ bliver 265 C, hvilket kræver ca. 4 timer.Example 5 In a glass flask equipped with reflux condenser and ammonia supply tubes, a reflux of 6.5 g (0.02 mol) of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-3,8,8-dihydropyrido is heated under reflux. 2,3-d] pyrimidine of Example 1 in 40 cm of ethanol under a rapid flow of NH The process is continued until the melting point of the solid (originally 176 ° C) becomes 265 C, which requires approx. 4 hours.

15 315 3

Blandingen afkøles, og der tilsættes 100 cm vand. Bundfaldet lufttørres, vaskes med vand og tørres. Man får 3,04 g (57,5%) 2-amino-6-carbethoxy-8-ethyl-5-oxo-5,8-dihydropyri-2Q do[2,3-d]pyrimidin, som renses ved omkrystallisation af ethanol. Smeltepunkt 266° C.The mixture is cooled and 100 cm of water is added. The precipitate is air dried, washed with water and dried. There are obtained 3.04 g (57.5%) of 2-amino-6-carbethoxy-8-ethyl-5-oxo-5,8-dihydropyri-2Qdo [2,3-d] pyrimidine which is purified by recrystallization from ethanol. Melting point 266 ° C

Analyse for ci2H14N4°3 (262/26) 25 Beregnet % C 54,95 H 5,38 N 21,37Analysis for C12 H14 N4 ° 3 (262/26) Calculated% C 54.95 H 5.38 N 21.37

Fundet % C 55,35 H 5,58 N 21,17Found% C 55.35 H 5.58 N 21.17

Hydrolyse af denne ester giver 2-amino-8-ethyl-5-oxo-5,8-di- hydropyrido[2,3-d]pyrimidin-6-carboxylsyre, smeltepunkt 292° C.Hydrolysis of this ester gives 2-amino-8-ethyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acid, m.p. 292 ° C.

3030

Eksempel 6 1.6 g 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihy- 3 35 dropyrido[2,3-d]pyrimidin og 1,6 g pyrrolidin i 2Q cm iso- propanol omrøres og opvarmes under tilbagesvaling. Efter opløsning af sulfonen udfældes reaktionsproduktet hurtigt. Op-varmingen fortsættes 1 time, blandingen afkøles, og det fas-Example 6 1.6 g of 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine and 1.6 g of pyrrolidine in 2Q cm of isopropanol are stirred. and heated at reflux. After dissolving the sulfone, the reaction product precipitates rapidly. The heating is continued for 1 hour, the mixture is cooled and the

Claims (6)

1. Fremgangsmåde til fremstilling af 8-substituerede 2-ami-no-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-6-carboxylsyrer med den almene formel js /C00H ! \N _L Ji jj (Illa) \.R,/ I« i2 20 hvor er en alkylgruppe med 1-5 carbonatomer, fortrinsvis 1-2 carbonatomer, en fenylgruppe eller benzylgruppe, R og R1, der kan være ens eller forskellige, hver er hydrogenatomer eller alkylgrupper med 1-5 carbonatomer eller sammen med nitrogenatomet , hvortil de er bundet, danner, en piperazinvl-25 gruppe, methyl-4-piperazinylgruppe, formyl-4-piperazinylgrup- pe, (4-|3-hydroxyethyl) -piperazinylgruppe eller pyrrolidino-gruppe, kendetegnet ved, at man omsætter en 8-substitueret 2-alkylsulfonyl-6-carbalkoxy-5-oxo^-5,8-dihydro- pyrido[2,3-d]pyrimidin med formlen 30 O 3 COOR Rl_! fTj «χ» R I ^ nA n XA process for the preparation of 8-substituted 2-amino-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acids of the general formula Wherein is an alkyl group having 1-5 carbon atoms, preferably 1-2 carbon atoms, a phenyl group or benzyl group, R and R 1, which may be the same or different, each are hydrogen atoms or alkyl groups having 1-5 carbon atoms or together with the nitrogen atom to which they are attached form a piperazinyl group, methyl 4-piperazinyl group, formyl-4-piperazinyl group, (4- | 3-hydroxyethyl) - piperazinyl group or pyrrolidino group, characterized by reacting an 8-substituted 2-alkylsulfonyl-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine of the formula Rl_! fTj «χ» R I ^ nA n X 35. I35. I 0 R20 R2 14 DK 152497 B 12 3 hvor R , R og R , der kan være ens eller forskellige, er alkylgrupper med 1-5 carbonatomer, fortrinsvis 1-2 carbon-atomer, og R desuden kan være en fenylgruppe eller benzyl-gruppe, med en amin af formlen 5 /"X 1 >NH hvor R og R' har den ovennævnte betydning, hvorefter en dannet 8-substitueret 2-amino-6-carbalkoxy-5-oxo-5,8-dihydropy-rido[2,3-d]pyrimidin med formlen III 0 ! 5 , ' N COOR3 \ (ΙΠ) ' -R' ^ 2 3 hvor R, R', R og R har den ovennævnte betydning, hydrolyseres . 20Wherein R, R and R, which may be the same or different, are alkyl groups having 1 to 5 carbon atoms, preferably 1-2 carbon atoms, and R may additionally be a phenyl group or benzyl group having a amine of the formula 5 / "X 1> NH wherein R and R 'have the above meaning and then an 8-substituted 2-amino-6-carbalkoxy-5-oxo-5,8-dihydropyrido [2,3- d) pyrimidine of the formula III 0, 5, N COOR 3 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at reaktionen mellem alkylsulfonyIderivatet (I) og aminen ud- o føres ved en temperatur mellem 60 og 120 C. 25Process according to claim 1, characterized in that the reaction between the alkylsulfonyl derivative (I) and the amine is carried out at a temperature between 60 and 120 ° C. 3. Fremgangsmåde ifølge krav 1, kendetegnet ved, at reaktionen udføres i et opløsningmiddel der muliggør fuldstaai-dig opløsning af reaktionsdeltagerne, især en a lky lal ko hol: ned 1-5 cafbonatomer.Process according to claim 1, characterized in that the reaction is carried out in a solvent which allows complete dissolution of the reaction participants, especially an alkali carbon: down from 1 to 5 carbon atoms. 3 DK 152497B te stof lufttørres og vaskes med 2 x 5 cm ethanol. Man får 1,38 g (udbytte 92%) 6-carbethoxy-8-ethyl-5-oxo-2-pyrrolidi-no-5,8-dihydropyrido[2,3-d]pyrimidin, smeltepunkt 202° C. Hydrolyse af denne ester giver 8-ethyl-5-oxo-2-pyrrolidino- _ 5,8-dihydropyr ido[2,3-d]pyrimidin-6-carboxylsyre, smelte- 5 punkt 314° C. Patentkrav. 1 o3 DK 152497B tea substance is air dried and washed with 2 x 5 cm ethanol. 1.38 g (yield 92%) of 6-carbethoxy-8-ethyl-5-oxo-2-pyrrolidino-5,8-dihydropyrido [2,3-d] pyrimidine, m.p. 202 ° C. this ester gives 8-ethyl-5-oxo-2-pyrrolidino-5,8-dihydropyrido [2,3-d] pyrimidine-6-carboxylic acid, mp 314 ° C. 1 o 4. Fremgangsmåde ifølge krav 1, kendetegnet ved, o U at reaktionen udføres ved at anvende et overskud af amin på 1,5-2 mol pr. mol alkylsulfonylderivat.Process according to claim 1, characterized in that the reaction is carried out using an excess of amine of 1.5-2 moles per ml. moles of alkylsulfonyl derivative. 5. Fremgangsmåde ifølge krav 1, kendetegnet ved, 35 at reaktionen udføres i nærværelse af et basisk middel, for trinsvis.en tertiær . alkylaminV - især. triethylamin. DK 152497BProcess according to claim 1, characterized in that the reaction is carried out in the presence of a basic agent, step by step, tertiary. alkylamine V - especially. triethylamine. DK 152497B 6. Fremgangsmåde ifølge krav 1, kendetegnet ved, at man lader 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo- 5,8-dihydropyrido[2,3-d]pyrimidin reagere med piperazin i form af hexahydrat; til dannelse af 6-carbethoxy-8-ethyl-5-oxo-2-piperazinyl-5,8-di.hydropyrido[2,3-d]pyrimidin, som man hydrolyserer til dannelse af den tilsvarende syre. 10 20 25 30 35Process according to claim 1, characterized in that 6-carbethoxy-8-ethyl-2-methylsulfonyl-5-oxo-5,8-dihydropyrido [2,3-d] pyrimidine is reacted with piperazine in the form of hexahydrate; to give 6-carbethoxy-8-ethyl-5-oxo-2-piperazinyl-5,8-dihydropyrido [2,3-d] pyrimidine which is hydrolyzed to give the corresponding acid. 10 20 25 30 35
DK100275A 1974-03-14 1975-03-12 METHOD FOR PREPARING 8-SUBSTITUTED 2-AMINO-5-OXO-5,8-DIHYDROPYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID DK152497C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11538/74A GB1484138A (en) 1974-03-14 1974-03-14 Pyrido pyrimidine derivatives
GB1153874 1974-03-14

Publications (3)

Publication Number Publication Date
DK100275A DK100275A (en) 1975-09-15
DK152497B true DK152497B (en) 1988-03-07
DK152497C DK152497C (en) 1988-08-01

Family

ID=9988077

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100275A DK152497C (en) 1974-03-14 1975-03-12 METHOD FOR PREPARING 8-SUBSTITUTED 2-AMINO-5-OXO-5,8-DIHYDROPYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID

Country Status (13)

Country Link
JP (1) JPS5929595B2 (en)
CA (1) CA1038870A (en)
CH (1) CH603642A5 (en)
CS (1) CS193510B2 (en)
DD (2) DD123606A5 (en)
DK (1) DK152497C (en)
FR (2) FR2299336A1 (en)
GB (1) GB1484138A (en)
IN (1) IN141366B (en)
NL (1) NL7503113A (en)
RO (1) RO65404A (en)
SE (1) SE7502845L (en)
YU (1) YU39114B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326118A1 (en) 1982-08-02 1984-02-09 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Pyridopyrimidinetriones, processes for their preparation, their use and medicaments containing them
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
US4851535A (en) * 1985-01-23 1989-07-25 Toyama Chemical Co., Ltd. Nicotinic acid derivatives
JP2000232222A (en) * 1999-02-10 2000-08-22 Nec Corp Manufacture of semiconductor device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152731B (en) * 1972-08-02 1988-05-02 Bellon Labor Sa Roger ANALOGY PROCEDURE FOR PREPARING 8-ALKYL-5-OXO-5,8-DIHYDRO-PYRIDO (2,3-D) PYRIMIDIN-6-CARBOXYL ACID

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1451912A (en) * 1972-08-14 1976-10-06 Dainippon Pharmaceutical Co 2-1-piperazino-5-oxopyrido-2,3-d-pyridine-6-carboxylic acids their preparation and pharmaceutical compositions thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152731B (en) * 1972-08-02 1988-05-02 Bellon Labor Sa Roger ANALOGY PROCEDURE FOR PREPARING 8-ALKYL-5-OXO-5,8-DIHYDRO-PYRIDO (2,3-D) PYRIMIDIN-6-CARBOXYL ACID

Also Published As

Publication number Publication date
DK100275A (en) 1975-09-15
RO65404A (en) 1980-06-15
CS193510B2 (en) 1979-10-31
CA1038870A (en) 1978-09-19
JPS50129596A (en) 1975-10-13
FR2299336B1 (en) 1979-03-30
NL7503113A (en) 1975-09-16
YU60075A (en) 1982-02-28
FR2289507A1 (en) 1976-05-28
CH603642A5 (en) 1978-08-31
DD123606A5 (en) 1977-01-05
IN141366B (en) 1977-02-19
DD120021A5 (en) 1976-05-20
JPS5929595B2 (en) 1984-07-21
DK152497C (en) 1988-08-01
YU39114B (en) 1984-06-30
SE7502845L (en) 1975-09-15
FR2289507B1 (en) 1978-11-10
FR2299336A1 (en) 1976-08-27
GB1484138A (en) 1977-08-24

Similar Documents

Publication Publication Date Title
PL94081B1 (en)
NO830800L (en) PROCEDURE FOR PREPARATION OF O-SUBSTITUTED DERIVATIVES OF (+) - CYANIDAN-3-OL
US2259222A (en) Preparation of sulphanilamide derivatives
NO153530B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED HETEROCYCLIC BENZAMIDES.
DK152497B (en) METHOD FOR PREPARING 8-SUBSTITUTED 2-AMINO-5-OXO-5,8-DIHYDROPYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID
DK175037B1 (en) Process for the preparation of quinoline carboxylic acid derivatives and intermediates which may be used in the process
US2621162A (en) J-propargyl-x-quinazolones and acid
US4151210A (en) Process for the production of phenylalkyl sulphones
US2335221A (en) Therapeutically useful heterocyclic compounds
NO141137B (en) DEVICE FOR READING A PLATE-SHAPED RECORD CARRIER
US2275354A (en) Preparation of new therapeutically useful heterocyclic compounds
US4125720A (en) Process for the preparation of 4-chloro-5-alkoxycarbonyl-2-methoxy-pyrimidines
JPH0372073B2 (en)
DK150850B (en) PROCEDURE FOR MANUFACTURING TRICYCLIC COMPOUNDS
CS261250B2 (en) Method of 1-methylaminoquinolinecarboxyl acid's and its derivatives production
NO742245L (en)
JPS6232753B2 (en)
KR0128029B1 (en) Process for the preparation of benzoxazine carboxylic acid derivatives
KR910004177B1 (en) Anilinopyrimidine derivatives
PL98600B1 (en) METHOD OF MAKING 8-SUBSTITUTED 2-AMINO-5-KETO-5,8-DIHYDROPYRIDO / 2,3-D / PYRIMIDINE-6-CARBOXYLIC ACIDS
KR920003690B1 (en) Process for preparation of quinoline derivatives
US2652401A (en) Benzothiazole derivatives and method of production
KR950012536B1 (en) Process for the manufacture of 2-nitro-4-sulfamyl-diphenyl amine dyes
DK158268B (en) Procedure for production of pyridobenzoxazine-derivatives
KR860000671B1 (en) Process for preparing piperazinyl derivatives of quinoline carboxylic acid

Legal Events

Date Code Title Description
PBP Patent lapsed